Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Thermo Fisher’s $44.6B year: $16.5B in deals, AI and cancer diagnostics

Summary by stocktitan.net
Q4 EPS rose to $5.21 GAAP and $6.57 adjusted as Thermo Fisher deployed $16.5B into M&A and buybacks. Management outlines 2026 outlook on today’s call.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

1 Articles

stocktitan.netstocktitan.net

Thermo Fisher’s $44.6B year: $16.5B in deals, AI and cancer diagnostics

Q4 EPS rose to $5.21 GAAP and $6.57 adjusted as Thermo Fisher deployed $16.5B into M&A and buybacks. Management outlines 2026 outlook on today’s call.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

stocktitan.net broke the news in on Thursday, January 29, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Artificial Intelligence icon

Artificial Intelligence

Mergers & Acquisitions icon

Mergers & Acquisitions

Business & Markets icon

Business & Markets

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal